[
  {
    "ts": "2025-12-29T13:52:00+00:00",
    "headline": "Here's Why You Should Retain Glaukos Stock in Your Portfolio Now",
    "summary": "GKOS appears well-positioned for long-term growth as iDose TR adoption accelerates and Epioxa secures FDA approval, although reimbursement and execution risks remain.",
    "url": "https://finance.yahoo.com/news/heres-why-retain-glaukos-stock-135200432.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9c8d7af8-540c-31b5-80f0-7ff34c7728ce",
      "content": {
        "id": "9c8d7af8-540c-31b5-80f0-7ff34c7728ce",
        "contentType": "STORY",
        "title": "Here's Why You Should Retain Glaukos Stock in Your Portfolio Now",
        "description": "",
        "summary": "GKOS appears well-positioned for long-term growth as iDose TR adoption accelerates and Epioxa secures FDA approval, although reimbursement and execution risks remain.",
        "pubDate": "2025-12-29T13:52:00Z",
        "displayTime": "2025-12-29T13:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9",
          "originalWidth": 620,
          "originalHeight": 392,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o9LS5iC6GqjU7Yfw5X9cbg--~B/aD0zOTI7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9.cf.webp",
              "width": 620,
              "height": 392,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z9BQ0wAoPzDqCAvoEDnE4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-glaukos-stock-135200432.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-glaukos-stock-135200432.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GKOS"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]